Clinical trial
Microbiota-derived Trimethylamine N-oxide as Residual Risk After ST-elevation Myocardial Infarction
NCT03418285 is registered in ClinicalTrials.gov with Yokohama City University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microbiota-derived Trimethylamine N-oxide as Residual Risk After ST-elevation Myocardial Infarction
- Lead sponsor
- Yokohama City University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2007
- Completion date
- January 1, 2018
- Enrollment
- 112 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.